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Live imaging studies of the processes of demyelination and remyelination have so far been technically limited inmammals.Wehave thus
generated a Xenopus laevis transgenic line allowing live imaging and conditional ablation of myelinating oligodendrocytes throughout
the CNS. In these transgenic pMBP-eGFP-NTR tadpoles the myelin basic protein (MBP) regulatory sequences, specific to mature oligo-
dendrocytes, are used to drive expression of an eGFP (enhanced green fluorescent protein) reporter fused to the Escherichia coli nitrore-
ductase (NTR) selection enzyme. This enzyme converts the innocuous prodrug metronidazole (MTZ) to a cytotoxin. Using two-photon
imaging in vivo, we show that pMBP-eGFP-NTR tadpoles display a graded oligodendrocyte ablation in response to MTZ, which depends
on the exposure time to MTZ. MTZ-induced cell death was restricted to oligodendrocytes, without detectable axonal damage. After
cessation of MTZ treatment, remyelination proceeded spontaneously, but was strongly accelerated by retinoic acid. Altogether, these
features establish theXenopus pMBP-eGFP-NTR line as anovel in vivomodel for the studyof demyelination/remyelinationprocesses and
for large-scale screens of therapeutic agents promoting myelin repair.
Introduction
The myelin sheath was a transformative vertebrate acquisition,
enabling at least a 50-fold increase in efficiency and velocity of
action potential propagation along axons without increase in di-
ameter (Zalc and Colman, 2000; Zalc et al., 2008). In the CNS,
myelin is synthesized by the oligodendrocyte. Multiple sclerosis
(MS) is an inflammatory and demyelinating CNS disease of the
young adult. Within MS plaques demyelination is associated with
loss of oligodendrocytes and often with axonal damage resulting
in neurological deficit. To date, available treatments for MS can
treat inflammation, but have little, if any, efficacy on remyelina-
tion. One way to facilitate repair of demyelinated lesions would
be to promote endogenous oligodendrocytes development and
their migration to the lesion sites. Unfortunately, the existing
mammalian models of MS are not ideally suited to follow in vivo
the process of demyelination and remyelination or for develop-
ing large-scale screens of compounds that promote myelin repair
in vivo (Miller and Fyffe-Maricich, 2010). Therefore, there is a
critical need for alternative animal models allowing live imaging
and monitoring of oligodendrocytes during the demyelination
and remyelination processes.
Small model organisms, such as amphibians and some te-
leosts, are increasingly being used at various stages of drug devel-
opment and constitute highly cost-effective alternative models to
mammals (Saito and van den Heuvel, 2002; De Smet et al., 2006;
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Giacomotto and Se´galat, 2010). Zebrafish and Xenopus embryos
are transparent and develop as free-living larvae and therefore are
particularly suited to investigate developmental processes at all
stages. To study myelination, demyelination and remyelination,
we have produced a transgenic Xenopus line (pMBP-eGFP-NTR)
designed to specifically express in oligodendrocytes the fluores-
cent reporter GFP fused to the Escherichia coli nitroreductase
(NTR), under the control of the 1.9 kb proximal portion of
mouse MBP regulatory sequence. Here, we show that the GFP
reporter is faithfully expressed in mature myelin-forming oligo-
dendrocytes that are specifically ablated following treatment with
metronidazole (MTZ, an NTR substrate). Treatment of pMBP-
eGFP-NTR tadpoles induces selective demyelination, which is
reversible on MTZ withdrawal. Two-photon microscopy allows
tracking of GFP expression and thus the processes of demyelina-
tion and remyelination in vivo on the same transgenic specimen.
Finally, using this in vivo model we show that spontaneous remy-
elination is dramatically increased upon exposure to retinoic
acid, a molecule recently shown to play an essential role in myelin
formation (Joubert et al., 2010; Latasa et al., 2010; Huang et al.,
2011). Thus, the pMBP-eGFP-NTR Xenopus line offers a novel
model to study demyelinization/remyelinization processes
and is ideally suited for in vivo large-scale screening of pro-
remyelinating drugs.
Materials andMethods
Animals. Xenopus tadpoles were raised and maintained as previously
described (de Luze et al., 1993) and staged according to the normal table
of Xenopus laevis (Daudin) of Nieuwkoop and Faber and developmental
progress defined as NF stages (Nieuwkoop and Faber, 1994). Tadpoles of
either sex were anesthetized in 0.05– 0.5% MS222 (3-aminobenzoic acid
ethyl ester; Sigma-Aldrich) before brain and spinal cord dissection. An-
imal care was in accordance with institutional and national guidelines.
Generation of the pMBP-eGFP-NTR construct and transgenic Xenopus
lines. The bacterial NfsB gene encoding NTR was directly amplified by
PCR from E. coli using the following oligos: 5-ATGCTCGAGCCATG
GATATCATTTCTGTCGCCTTA-3 and 5-GGGGATCCGATCGATC
TCAATACCCGCTAAATA-3, as previously described (Curado et al.,
2007). The amplification product was digested by XhoI and BamHI and
cloned in frame to eGFP in the peGFP-C1 vector (Clontech) to produce
the CMV-eGFP-NTR construct. This vector was used to amplify the
eGFP-NTR fusion cDNA using two flanking primers containing BamHI
restriction sites at their 5 end, and the product was inserted into the
unique BamHI site of the pMG2 plasmid containing the 1.9 kb proximal
portion of mouseMBP regulatory sequence (Gow et al., 1992) to produce
the final pMBP-eGFP-NTR vector (Fig. 1A). The pMBP-eGFP-NTR plas-
mid was linearized with EcoRI and used to generate stable transgenic
Xenopus laevis embryos using a simplified restriction enzyme-mediated
integration (REMI) procedure (Kroll and Amaya, 1996; Sparrow et al.,
2000; Chesneau et al., 2008). F0 animals were crossed to wild-type Xeno-
pus to generate lines, one of which was selected that carry a single trans-
Figure 1. Structure and expression of the pMBP-eGFP-NTR transgene.A, Schematic diagram of the pMBP-eGFP-NTR construct. The transgene contains the eGFP open reading frame fused to that
of E. coli NTR placed under the control of the DNA regulatory sequence of the murineMBP gene (1907 bp and36 bp). B, RT-PCR performed on RNA extracted from brains of transgenic (TG) or
wild-type (WT) tadpoles used to amplify a 394 bp fragment corresponding to the junction of eGFP/NTR sequence. C–F, Transgene expression as assessed by GFP fluorescence (C–E) or immunola-
beling (F ) in a pMBP-eGFP-NTR transgenic tadpole at stage 55. Dorsal view of the head (C) and sagittal view of the tail (D). Expression is only observed in the CNS (brain and spinal cord) but not in
theperipheral nervous system. Inset inC is a highermagnification to illustrate thedetection of GFP in the optic nerve.E, In vivo stack of images of the optic nerve obtainedby two-photonmicroscopy.
Note the fluorescent processes of the GFP cells. F, Confocal image of awholemount of the optic chiasm immunostained forMBP (red) and GFP (green). Note the GFP cell bodies extending their
processes toward the strongly MBPmyelinated fibers. Scale bar (in E) C, D, 2 mm; E, F, 50m; inset (C), 1 mm.
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gene integration site. Transgenic embryos were genotyped by assessing
the presence of eGFP/NTR fusion transcripts by reverse transcriptase
(RT)-PCR using the forward primer 5-ACGTCTATATCATGGCCG
ACAAG-3 and reverse primer 5-TGCAGTAGCGTTTTGATCTGCT
C-3 located on either side of the eGFP/NTR junction to amplify a 394 bp
fragment. To this end, 2 g of total RNA extracted from brains were
reverse transcribed using the SuperScript II kit (Invitrogen) according to
the manufacturers’ instructions and used as template for the PCR. The
fusion protein (GFP/NTR) was detected directly by fluorescence in live
embryos using an AZ100 Nikon Zoom Microscope.
Metronidazole preparation and use. MTZ (Fluka) was dissolved in fil-
tered tap water containing 0.1% DMSO (Sigma Aldrich). Preliminary
experiments demonstrated that high concentrations ( 20 mM) of MTZ
were toxic. Therefore, MTZ was used at concentrations of 10 or 15 mM
and exposure time ranged from 3 to 11 d. Control animals were kept in
the same media without MTZ. Furthermore, transgenic or nontransgenic
sibling tadpoles were maintained in 600 ml of MTZ solution (maximum 10
tadpoles/600 ml) at 20°C in complete darkness (MTZ is light-sensitive) and
daily changed throughout the duration of treatment. For regeneration ex-
periments, MTZ-treated animals were allowed to recover for up to 6 d in
normal water in ambient laboratory lighting.
Transgenic tadpoles were treated with drugs between stage NF 48 and
55. These stages correspond to pre-metamorphosis and represent stages
in which myelination is ongoing. Myelination markers such as proteo-
lipid protein (PLP) and myelin basic protein (MBP) are first immuno-
detected at stages 42/43 in the hindbrain and spread throughout the brain
and spinal cord by stages 46/47 (Yoshida, 1997). In the optic nerve at the
electron microscopic (EM) level myelination was reported to begin in the
middle portion at stage 48/49 and the number of myelinated axons in-
creases sevenfold between stage 50 and 57 (Cima and Grant, 1982).
Immunohistochemistry.Tadpoles were fixed by immersion in 4% para-
formaldehyde, rinsed in 1 PBS, cryoprotected in 30% sucrose (1
PBS) and frozen embedded in OCT (Tissue Tek). Cryosections (12 m)
were blocked in 10% normal goat serum in 1 PBS containing 0.1%
Triton X-100 and incubated overnight at 4°C with primary antibodies.
For whole-mount immunolabeling, dissected fixed brains were first in-
cubated for 2 d at 4°C in primary antibody and then overnight at 4°C with
secondary antibody. The brains were rinsed extensively in 0.1% Triton
X-100 following antibody incubations and before mounting. The following
primary antibodies were used for immunostaining: mouse anti-GFP (1:
1000, Invitrogen), rabbit anti-activated-caspase3 (1:250, BD PharMingen),
mouse anti-APC (Ab7) (1:500, Calbiochem), anti-Nkx2.2 (1:10, mouse hy-
bridoma, Developmental Studies Hybridoma Bank, Iowa City, IA), mAb to
phosphorylated neurofilaments (mouse IgG1 SMI 31; 1/500, Covance),
mouse anti-MBP monoclonal antibodies (directed against Xenopus MBP,
1:1000, kindly provided by Saburo Nagata, Women’s Tokyo University, Ja-
pan), anti-pan-neurofascin (NFC1) (1:1000; Zonta et al., 2008), and anti-Hu
(1:10,000 Human serum, kindly provided by Dr. Jean-Yves Delattre, Centre
de Recherche de l’Institut du Cerveau et de la Moelle e´pinie`re, Groupe Hos-
pitalier Pitie´-Salpeˆtrie`re, France). Specific binding sites were visualized using
anti-mouse or anti-rabbit fluorescent secondary antibodies (1:1000 Alexa
488 or 594, Invitrogen) and for Hu Ab, anti-human IgG F(c) coupled to
Texas Red (1:400, Rockland). Sections were stained in Hoechst solution
(Sigma-Aldrich) and mounted in FluorSave Reagent mounting medium
(Calbiochem).
Electronmicroscopy.Tadpoles were fixed in 2% paraformaldehyde, 2%
glutaraldehyde, 1% potassium ferricyanide in 0.1 M cacodylate buffer, pH
7.4 and 0.002% calcium chloride overnight at 4°C, washed in 0.1 M caco-
dylate buffer, and postfixed in 1% osmium tetraoxide, 1% potassium
ferricyanide in 0.1 M cacodylate buffer. After washing in cacodylate buffer
and water, tadpoles were incubated in 1% uranyl acetate aqueous solu-
tion at 4°C overnight. After rinsing twice in water, tadpoles were dehy-
drated in increasing concentrations of ethanol, washed in increasing
concentrations of 2-hydroxypropyl methacrylate (Electron Microscopy
Sciences) dissolved in 90% ethanol, infiltrated, and embedded in Epon-
BDMA solution (Epon, benzyl dimethylamine; Electron Microscopy Sci-
ences). Blocks were heated at 70°C for 72 h. Ultrathin sections (70 nm)
were examined on an EM208 electron microscope (Philips).
Histology and Luxol fast blue staining. Tadpoles were fixed for 48 h at
room temperature in 3.8% formaldehyde in water. Paraffin sections (6
m) were stained with Luxol fast blue as previously described (Geisler et
al., 2002). Briefly, rehydrated sections were immersed in a Luxol fast
blue-0.1% ethanol solution at 60°C for 24 h and washed in distilled water.
The slides were differentiated in 0.05% lithium carbonate solution for
30 s and then in 70% ethanol for 30 s. Slides were counterstained in cresyl
violet solution for 30 – 40 s. After rinsing in distilled water, the slides were
differentiated in 95% ethanol for 5 min in 100% ethanol and mounted
with Eukitt medium (Sigma Aldrich). As a result of these staining proce-
dures, myelinated fibers are stained blue, and neuronal cell bodies are
stained pink to violet.
Two-photon observation. For in vivo examination of GFP-expressing
oligodendrocytes along the optic nerve, tadpoles were anesthetized in
MS222 and placed in a POC-Chamber-System (H. Saur), under a two-
photon microscope. Mono-photon or two-photon excitation was per-
formed using Zeiss LSM 710 microscope system. The microscope was
equipped with objective (20, 1 NA). Calculated optical slice thickness
was 2 m. Each image presented is the 3D projection of 18 –26 stacks of
images. The settings (gain and aperture pinhole) were held constant
within individual experiments. All images shown were processed with
ImageJ software (NIH).
Quantification of GFP cells. In the optic nerve, the total number of
GFP cells was counted, from the emergence of the nerve to the retinal
end before and after MTZ treatment on the same embryos and data were
compared with control untreated animals of the same developmental
stage. On medulla preparations, quantification of GFP cells was per
tissue sections and each data point is the mean value of six sections from
one tadpole. Data presented are the mean  SEM of number of GFP
cells counted on 6 tadpoles (n 6).
Statistical analysis. Prism v5 software (GraphPad) was used for statis-
tical analyses. Results are expressed as means  SEM. Data were com-
pared using Student’s t test. Statistical significance was set at p 0.05.
Results
Oligodendrocyte-restricted expression of a dual reporter/
selection transgene in Xenopus laevis
The proximal regulatory sequences of the murine myelin MBP
gene contain enhancer and promoter elements localized between
Movie 1. Faint detection of GFP in myelin along optic nerve axons of stage 50 pMBP-eGFP-
NTR transgenic tadpole. At this early developmental stage, the wrapping process is ongoing,
therefore myelin is still not completely compact and this allows diffusion of GFP in the myelin
cytoplasmic compartment. This movie represents the Z-projection of 17 successive optical sec-
tions across the thickness of the optic nerve imaged by two-photon microscopy.
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position 36 and 1907, which are sufficient for a strong and
specific expression in mature oligodendrocytes (Gow et al., 1992;
Stankoff et al., 1996). As shown in Figure 1A, this 1.9 kb proximal
regulatory sequence is used to drive expression of a dual reporter/
selection transgene (eGFP-NTR) composed of the enhanced
green fluorescent protein (eGFP) reporter gene fused in frame
with the bacterial nfsB gene encoding the NTR enzyme for MTZ-
dependent cell ablation (Curado et al., 2007). The pMBP-eGFP-
NTR vector was used for REMI transgenesis in Xenopus laevis.
Several transgenic founders (F0) were generated and crossed to
wild-type animals to obtain F1 progenies. F1s were then geno-
typed by RT-PCR to confirm the expression of the fusion GFP/
NTR transcript and to characterize the number of integration
sites for each line (Fig. 1B).
Indicative of transgene expression in the pMBP-eGFP-NTR
tadpole the first GFP cells were detected at stage 41– 42 within
the brainstem (data not shown). At stage 55, GFP-expressing
cells were detected exclusively in the brain (Fig. 1C), spinal cord
(Fig. 1D) and optic nerve, where fluorescence was clearly con-
fined to cell bodies extending thin processes, highly reminiscent
of oligodendrocytes (Fig. 1E,F). It should be noted that, as GFP is
cytoplasmic, fluorescence was not detected in the myelin sheath.
Figure 2. The pMBP-eGFP-NTR transgene drives expression inmature oligodendrocytes. Coronal tissue sections across themedulla of pMBP-eGFP-NTR tadpole at stage 55 coimmunostained for
GFPand successivemarkers of different cells types.A–C, GFPandAPC, a specificmarker ofmatureoligodendrocytes.Note the completeoverlapofGFP labelingwith that ofAPC.D–F, GFPandNkx2.2,
amarker of progenitor of oligodendrocytes andmature oligodendrocytes. Note that cells doubly labeled for GFP andNkx2.2 are localized in thewhitematter tract,with noGFP detection inNkx2.2
progenitors in the ventral ventricular layer (white arrows inF ).G–I, GFP andGFAP, amarker of astrocytes. J–L, GFP andHu, a pan-neuronalmarker. Note the complete exclusion of GFP labelingwith
either GFAP (I ) or Hu (L). Scale bar (in C) A–F, J–L, 50m; G–I, 25m.
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Figure 1F shows a whole mount of the chiasm double-labeled
with anti-GFP and -MBP antibodies. GFP cells extend pro-
cesses toward the internode region of axons where MBP expres-
sion is mostly concentrated in the myelin sheath (Ainger et al.,
1997). However, during the process of wrapping before myelin
compaction, GFP can diffuse in the cytoplasmic compartments
of myelin and it was possible to detect early myelination in vivo.
Indeed, at stage 50, i.e., at a stage when myelination is ongoing,
oligodendrocyte processes extending along axons were clearly
visible as illustrated on a stack of 17 optical sections of the optic
nerve (Movie 1). As development proceeds, the distribution of
GFP cells extends from the brainstem, caudally to the spinal
cord and rostrally to the forebrain, following the expected pattern
of myelination in mammals (Kanfer et al., 1989). We could not
detect expression of the transgene in the peripheral nervous sys-
tem (PNS). This result is in agreement with the observation that
the 1.9 kb MBP regulatory sequence drives MBP expression in
oligodendrocytes, while in Schwann cells,MBP expression is con-
trolled by a different 422 bp enhancer 9 kb upstream of the
transcriptional initiation site (Denarier et al., 2005).
To confirm the specific expression of the eGFP/NTR trans-
gene in mature oligodendrocytes, cryosections from pMBP-
eGFP-NTR transgenic tadpoles at stage 55 were double labeled
with antibodies against GFP and cell type-specific markers, i.e.,
APC (adenomatous polyposis coli) for mature oligodendrocytes
(Bhat et al., 1996), Nkx2.2 transcription factor for oligodendro-
cyte precursor cells and mature oligodendrocytes (Soula et al.,
2001; Yoshida and Macklin, 2005), GFAP (glial fibrillary protein)
for astrocytes (Eng et al., 1971), and Hu RNA-binding protein for
neurons (Graus and Ferrer, 1990; Fig. 2). All sections examined
showed a complete superimposition of GFP and APC labeling,
with all GFP cells expressing APC and all APC cells expressing
eGFP (Fig. 2A–C). This observation bolsters the argument that
GFP/NTR expression is restricted to oligodendrocytes. In the
ventral ventricular domain of the medulla, Nkx2.2 progenitor
cells did not express GFP. In contrast, white matter tracts showed
a vast majority of Nkx2.2/GFP cells, which are likely mature
oligodendrocytes (Fig. 2D–F). In addition, GFP expression was
detected neither in GFAP-expressing astrocytes (Fig. 2G–I) nor
in Hu neurons (Fig. 2 J–L), These data demonstrate the strict
oligodendroglial expression of the eGFP-NTR transgene in tad-
poles and suggest that, both in mice and Xenopus, the 1.9 kb
regulatory sequence of MBP selectively drives transgene expres-
sion in mature myelin-forming oligodendrocytes.
MTZ treatment induces oligodendrocyte depletion and
demyelination in aMTZ-dependent manner
We next tested the ability of NTR to render oligodendrocytes
susceptible to drug-dependent ablation by treating transgenic
tadpoles with increasing concentrations of MTZ. Preliminary ex-
periments showed that treatment of stage 55 tadpoles with 20 mM
MTZ (or higher concentrations) was toxic. Hence, tadpoles were
treated with 10 or 15 mM MTZ for 3 or 6 d. The number of GFP
cells per optic nerve was highly reproducible and increased pro-
gressively as a function of development (7 2, 25 3, and 31
2 at stages 48, 50, and 55 respectively). Progressive MTZ-induced
oligodendrocyte cell death in transgenic tadpoles was monitored
Figure 3. Oligodendrocyte depletion and apoptosis in transgenic tadpoles following MTZ treat-
ment.A,B,Whole-mount two-photonmicroscopyof theopticnerveat stage55showingGFP cells
in transgenic animals untreated (A) or MTZ-treated for 3 d (B). MTZ induced a severe depletion of
GFP cells in the optic nerve. C–H, Immunolabeling for GFP and activated caspase3 (Casp3) on
coronal sectionsacross themedulla inuntreated(C,E,G)orMTZ-treated(D,F,H ) transgenicanimals.
InMTZ-treated animals, activated caspase3 is detected in GFP cells. Scale bar (inG)A,B, 150m;
C–H, 50m.
Movie2. Live imagingof anoligodendrocyte cell death causedbyMTZ treatment. A stage55
tadpolewas treatedwithMTZ for 5 d. The optic nervewas visualized by two-photonmicroscopy
between one and four times a day for 5 d. On day 6, when the pattern of fluorescence of one
oligodendrocyte (arrow) in the field of observation changed dramatically, indicative that the
cell was entering apoptosis, we imaged four times at 90 min intervals.
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on live embryos by successive examina-
tions of the optic nerve of the same animal
under either a fluorescent macroscope or
a two-photon microscope.
In vivo examination of the optic nerve
of MTZ-treated stage 55 tadpoles (10 mM
for 3 d) resulted in a 50% depletion of
GFP cells per optic nerve (Fig. 3A,B).
Quantification showed that this reduction
was highly significant: 31  2 in controls
versus 16  2 after 72 h MTZ treatment
(p 0.001 n 6 tadpoles). A similar de-
pletion of GFP oligodendrocytes was
observed in medulla sections (Fig. 3C–H):
42  2 in controls vs 22  1 after MTZ
treatment, number of GFP cells per tis-
sue section (p 0.0001, n 6 tadpoles).
Oligodendroglial cell death following
MTZ treatment occurred by apoptosis
as double immunostaining showed that
most GFP cells were also positive for
anti-caspase 3 staining in MTZ-treated
tadpoles (Fig. 3D,F,H). This result con-
trasted with the absence of caspase3/
GFP cells in untreated tadpoles (Fig.
3C,E,G). Apoptosis was also confirmed at
an earlier developmental stage by TUNEL
(terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end
labeling) assays (data not shown). Live
imaging in the optic nerve of the death of
an oligodendrocyte consecutive to MTZ
treatment of a stage 55 tadpole is illus-
trated in Movie 2.
Since GFP cells are mature myelinat-
ing oligodendrocytes, ablation of these
cells should lead to a severe demyelina-
tion. As illustrated on medulla sections,
MTZ-treated tadpoles showed a marked
decrease in the density of Luxol fast blue-
stained fibers compared with untreated
controls (Fig. 4A,B). It was previously
shown that disorganization of nodes of
Ranvier is a good indicator of demyelina-
tion (Howell et al., 2006; Pernet et al.,
2008). To confirm that demyelination oc-
curred in MTZ-treated pMBP-eGFP-NTR
tadpoles, we analyzed the nodes of Ranvier
organization using pan-neurofascin anti-
bodies directed against neurofascin iso-
forms NF155 and NF186, which are
expressed at the paranodal and nodal do-
mains, respectively (Zonta et al., 2008,
2011). Immunolabeling of tadpole optic nerve sections with pan-
neurofascin antibodies showed, as in the mouse, an intense stain-
ing at the paranodal domains (probably corresponding to glial
NF155) and a weaker, although clearly detectable, staining (ax-
onal NF186) of the node (Fig. 4C, inset).
To determine the extent of demyelination process induced by
MTZ treatment, we next examined whole mounts of optic nerves,
isolated from control and MTZ-treated pMBP-eGFP-NTR tad-
poles, stained with both pan-neurofascin and anti-neurofilament
(SMI-31) antibodies. Following 3 d of MTZ treatment, SMI-31
axons do not appear to be altered (Fig. 4G,H), while numerous
neurofascin hemiparanodes (Fig. 4F, inset) were observed, in-
dicative of a partial demyelination (Fig. 4F,H). In contrast, un-
treated transgenic tadpoles showed a complete neurofascin
nodal staining, i.e., two paranodes on either side of each node of
Ranvier (Fig. 4C,E).
The characteristics of demyelination were further investi-
gated using electron microscopy. We counted the number of
myelinated axons in the dorsal medulla of control and MTZ-
treated transgenic tadpoles at stage 55. Controls showed ap-
Figure 4. MTZ treatment induces demyelination without axonal damage. A, B, Myelinated fibers staining with Luxol fast blue
on coronal sections across the medulla at stage 55 in untreated (A) or MTZ-treated (B) transgenic animals. C–H, Whole mount of
optic nerve at stage 55 immunostained for neurofascin (green) and SMI-31 (red) in untreated (C–E) or MTZ-treated (F–H )
transgenic animals. Insets in C and F are high magnifications of nodes of Ranvier showing a strong signal for NF 155 in the
paranodal domain and a weaker signal in the node (NF186) in a control animal (C), where in case of partial demyelination, only
hemiparanodes are labeled (F ). MTZ treatment induced demyelination, characterized by disorganization of the neurofascin
nodes of Ranvier (F, H ) with numerous heminodes compared with control (C, E). In MTZ-treated tadpoles, SMI-31 axons had a
normal appearance (G, comparedwithD), suggesting that MTZ-induced demyelination does not affect the axons. Scale bar (in F )
A, B, 17m; C–H, 5m; insets (C, F ), 2m.
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proximately one third of their axons
myelinated (31 2% of axons per section,
n  3800 fibers counted per animal; Fig.
5E,H). In contrast, after 6 d of MTZ treat-
ment, only 7  2% of axons remained
wrapped by a myelin sheath (Fig. 5F,H).
Tissues from MTZ-treated transgenic tad-
poles were also infiltrated by macrophages
displaying lipid droplets and phagocyted-
myelin debris (Fig. 5F, inset). The morphol-
ogy of naked axons was however normal,
confirming our observation following im-
munolabeling with SMI31 antibody (Figs.
4G, 5F). Therefore, MTZ treatment of
pMBP-eGFP-NTR tadpoles respects axonal
integrity, but induces demyelination by ap-
optotic cell death of oligodendrocytes. This
finding led us to analyze the potential for
spontaneous repair of oligodendrocytes and
myelin in pMBP-eGFP-NTR tadpoles after
interruption of the MTZ treatment.
Spontaneous remyelination after
interruption of the MTZ treatment
Stage 55 pMBP-eGFP-NTR tadpoles were
treated for 3 d with 10 mM MTZ and then
returned to normal water for 6 d. Animals
were then killed for examination of me-
dulla sections either by immunolabeling
with anti-GFP antibody or using electron
microscopy. As described above, 3 d of
MTZ treatment reduced by half the num-
ber of oligodendrocytes (Fig. 5A,B,D).
After 6 d of recovery, the population of
GFP cells had however strongly in-
creased and was nearly restored (n  6
tadpoles, p  0.0001; Fig. 5C,D). EM ex-
amination of tadpoles following 6 d of re-
covery confirmed a partial remyelination
of MTZ-induced demyelinated axons
(Fig. 5G,H), in agreement with the return
to nearly normal level of the number of
GFP cells (Fig. 5D). To investigate the
potential of spontaneous repair in vivo,
stage 55 tadpoles received the same treat-
ment (MTZ 10 mM for 3 d then 6 d in
normal water). Each treated tadpole was
submitted to repetitive two-photon
microscopy examinations. The disap-
pearance and reappearance of GFP oli-
godendrocyte cells was monitored in the
same specimen and at the same location
along the optic nerve (Fig. 6). Before treat-
ment, in the field illustrated in Figure 6 we
focused our observation on 6 GFP cells
(Fig. 6, T1). After 3 d of MTZ treatment, 3
cells were no longer observed (Fig. 6, T3)
and a fourth cell had disappeared on the
following observation (Fig. 6, R3). Two
cells resisted the MTZ treatment (aster-
isks). After 3 d of recovery, new GFP
cells appeared (Fig. 6, R3), and their num-
ber progressively increased (Fig. 6, R6).
Figure5. Quantificationofoligodendrocytedepletion,demyelinationand recoveryafter cessationofMTZ treatment.A–D, GFP immu-
nostainingof coronal sections across themedulla of stage55pMBP-eGFP-NTR tadpoles untreated (A), treated for 6dwith10mMMTZ (B),
andafter6dof recovery followingtreatmentcessation (C).D,Quantificationof thenumberofoligodendrocytes (GFP cells)per section in
control (CTL)MTZ-treated (MTZ) and after recovery (REC) (n6 tadpoles for each condition, ***p0.0001).E–H, Electronmicrograph
across themedulla of stage55 transgenic tadpole untreated (E) orMTZ-treated for 6d (F ). FollowingMTZ treatment,most of themyelin-
ated fibersdisappearedand thedemyelinatedareaswere invadedbymacrophages filledwith lipiddroplets andmyelindebris (inset inF ).
Notethenormalmorphologicalappearanceofaxons inMTZ-treatedtadpoles.G,Sixdaysaftertreatmentcessationalargenumberofaxons
are remyelinated. H, Quantification of myelinated axons expressed as percentage of total axons (n 3800 fibers scored per animal,
***p 0.0001). Scale bar (inG)A–C, 50m; E–G, 4m; inset (F ), 0.4m.
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After 6 d of recovery, the number of GFP
cells was approximately similar to control
conditions, indicative of a spontaneous
recovery mechanism.
pMBP-eGFP-NTR tadpole as a tool for
screening of remyelinating compounds
We then questioned whether we could use
this model to screen for molecules favor-
ing de novo oligodendrogenesis and ulti-
mately remyelination. As a proof of
concept, we tested the efficiency of reti-
noic acid (RA), since it has previously
been shown to increase myelination and
remyelination both in in vivo and ex vivo
models (Joubert et al., 2010; Latasa et al.,
2010; Huang et al., 2011). In a first set of
experiments, pMBP-eGFP-NTR tadpoles
at stage 48 were treated with 13-cis-
retinoic acid (100 nM). After 3 d of RA
treatment, the number of GFP cells per
optic nerve (16 3, n 10) was doubled
compared with untreated controls (7 2,
n  10), suggesting a strong promoting
effect of this retinoid X receptor agonist
on oligodendrogenesis. RA acted in a
dose-dependent manner, 10 and 50 nM
RA resulting in 15 and 20% increase in the
number of oligodendrocytes, respectively.
Finally, we tested the effect of RA on in vivo remyelination po-
tency. To induce an extensive demyelination, stage 50 pMBP-
eGFP-NTR tadpoles were treated with 10 mM MTZ for 11 d.
Tadpoles were then treated for 72 h with either 13-cis-retinoic
acid (100 nM) or vehicle added to the aquarium water. The effects
of MTZ followed by RA treatment were assessed by counting the
number of GFP oligodendrocytes in the optic nerve (Fig. 7).
This longer exposure to MTZ induced a drastic deletion of my-
elinated oligodendrocytes in the optic nerve, which was further
aggravated after 3 d in normal water. In contrast, the number of
optic nerve GFP cells was increased following a 3 d treatment
with RA.
Together these results lead us to propose the pMBP-eGFP-
NTR transgenic Xenopus line as a new, reliable and convenient
model for monitoring the process of oligodendrogenesis in vivo.
Discussion
We have generated a transgenic Xenopus line reliably and specif-
ically expressing the fluorescent reporter GFP fused to a suicide
gene in myelinating oligodendrocytes. This transgenic animal
should prove useful to investigate myelination and remyelina-
tion. To date, the mouse provides the most powerful mammalian
model for in vitro and in vivo modeling CNS myelination and
remyelination (Jarjour et al., 2012). However, despite impressive
improvements, live imaging remains complex and limited, both
during early development, since embryogenesis is intrauterine, and
during the postnatal period and adulthood due to the opacity of the
skull and vertebrae (Fenrich et al., 2012). To circumvent this diffi-
culty, some laboratories have developed transgenic zebrafish to take
advantage of the transparency of the embryos, and interesting results
have already been reported in this species (Kirby et al., 2006; Czopka
and Lyons, 2011; Perlin et al., 2011). However, as far as myelination
is concerned, the large difference in myelin protein composition of
zebrafish compared with mammals may limit the transposition of
data obtained in the zebrafish to higher vertebrates and human, in
particular. For instance, in teleosts the major CNS myelin protein is
a 36 kDa protein exhibiting no structural homology with any of the
known mammalian myelin proteins (Moll et al., 2003). Similarly,
bony fish oligodendrocytes (and CNS myelin) express protein zero
(P0), a strictly PNS myelin constituent in mammals (Lanwert and
Jeserich, 2001).
This situation contrasts with the numerous similarities be-
tween mammals and amphibian CNS myelin proteins. For in-
stance, PLP, the most abundant CNS myelin protein that
accounts for 50% of total myelin protein, has been shown to bear
a high degree of conservation between amphibian and mamma-
lian within the hydrophobic domains (Schliess and Stoffel, 1991;
Yoshida and Colman, 1996), and PLP emerged at the root of
tetrapods by the acquisition of an enlarged cytoplasmic loop in
the evolutionary older DM20 isoform (Mo¨bius et al., 2008). Sim-
ilarly, in Xenopus as in mammals, alternative transcripts encoding
Nogo protein are generated giving rise to Xenopus Nogo-A, -B, and
-C (Diekmann et al., 2005). Since Nogo-A is one of the myelin-
associated CNS axon growth inhibitor, this observation led the au-
thors to conclude that Nogo-A inXenopusmyelin might contribute
to the failure of spinal cord regeneration in frogs, a feature that may
have evolved during the transition from fish to land vertebrates.
Along the same line, we have been able to use antibodies raised
against the mouse pan-neurofascin (NF186 and NF155) to success-
fully label the nodal and paranodal domains of Xenopus myelinated
axons in the optic nerve as described in the mouse (Zonta et al.,
2011). Furthermore, not only the coding sequences of myelin pro-
tein between mouse and Xenopus are highly conserved, but regula-
tory sequences are also similar. In the mouse, it has been shown that
the1.9 kb proximal upstream sequence of mouseMBPgene drives
specific expression of the transgene in mature oligodendrocytes, but
not in Schwann cells (Gow et al., 1992; Stankoff et al., 1996). Here,
we show that this 1.9 kb regulatory sequence drives specifically trans-
Figure 6. Live imaging of oligodendrocyte depletion and reappearance following MTZ treatment and cessation. Successive
observation of the optic nerve of the same transgenic tadpole by two-photon microscopy. Transgenic tadpoles at stage 55 were
treated for 3 dwithMTZ (10mM) (T1, T3), then returned to normalwater for 6 d. Observationswere before treatment (T1), after 3 d
in the presence of MTZ (T3) and during recovery at 3 and 6 d in normal water (R3, R6). White arrows in T1 and T3 point to
oligodendrocytes that disappear with MTZ treatment. White asterisks indicate oligodendrocytes that survive the treatment. One
cell,whichwas still seenat T3, haddisappeared inR3. InR3, redarrowspoint tonewGFP cells thathaveappeared, during the first
3 d of recovery. Yellow arrows in R6 indicate additional GFP cells that have been generated between 3 and 6 d of recovery. Scale
bar, 15m.
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gene expression in mature oligodendrocytes and not Schwann cells
of Xenopus laevis tadpoles. Together, these results consolidate the
demonstration that the mouse MBP gene used in the present study
contains the regulatory information required for oligodendrocyte-
specific expression in tadpole and illustrates a functional conserva-
tion between the two species.
The E. coli suicide gene NTR activates the aziridine compound
CB1954 (5-aziridin-1-yl-2,4-dinitrobenzamide) into its cytotoxic
DNA interstrand cross-linking derivative. Among NTR substrates,
MTZ is preferred since its toxic form remains confined to the NTR-
expressing cell, allowing the exclusive ablation of NTR cells with-
out bystander effects (Bridgewater et al., 1995). This property
initially used to eliminate cancer cells (Bridgewater et al., 1995; Bailey
et al., 1996) has also been used to conditionally ablate different cell
types in transgenic animals. In the mouse, expression of NTR driven
by the control elements of the human CD2 locus has allowed to
induce an extensive and specific T cell depletion in thymus and
spleen (Drabek et al., 1997). More recently, transgenic expression of
NTR has been successfully used in zebrafish and Xenopus to induce
temporally controlled cell-specific ablation of cardiomyocytes, pan-
creatic -cells, hepatocytes and rod photoreceptors (Curado et al.,
2007, 2008; Pisharath et al., 2007; Choi et al., 2011). Here, we dem-
onstrate that the same experimental strategy can be exploited to
eliminate oligodendrocytes in a temporal- and spatial-specific man-
ner in a transgenicXenopus tadpole. We also show that the hydroxy-
amino derivative produced following NTR-catalyzed reduction of
MTZ kills cells predominantly by caspase-dependent apoptosis,
similar to the mechanism activated by CB 1954, an alternative sub-
strate of NTR (Palmer et al., 2003).
Understanding the molecular mechanisms controlling remy-
elination of axons in demyelinating diseases, like multiple sclero-
sis, is of significant clinical interest to define new therapeutic
targets aimed at inducing or increasing endogenous repair. The
different in vitro strategies to explore myelination and remyelina-
tion in rodents have recently been reviewed (Jarjour et al., 2012).
For in vivo studies of demyelination and remyelination, there is a
relatively large panel of experimental models in rodents and pri-
mates. Experimental autoimmune encephalitis (EAE) is probably
the most widely used model for MS, since it associates inflammation
and demyelination and mimics immunopathological characteristics
found in MS (for recent reviews, see Steinman and Zamvil, 2005;
Baker et al., 2011; Batoulis et al., 2011; Constantinescu et al., 2011).
Although EAE is far from being a perfect model for MS, most of
currently used treatments for MS have been investigated in EAE. To
be convincing, studies based on EAE require a large number of ani-
mals and are therefore costly and lengthy. This is due to the fact that
the localization and size of lesions are not predictable and highly
variable between animals and that the lack of reliable in vivomarkers
limits longitudinal studies of the same animal to evaluate biology of
the disease and remyelination. Moreover, the introduction of tar-
geted EAE (Kerschensteiner et al., 2004) has advanced the field being
readily applicable in the rat, but more delicate to apply in the mouse
(Tepavcˇevic´ et al., 2011).
In toxin-mediated models, the inflammatory component is
less important but the demyelination is localized, therefore facil-
itating analyses of demyelination and remyelination (Miller and
Fyffe-Maricich, 2010). The demyelinating property of lysoleci-
thin was first demonstrated in rat cerebellum myelinating cul-
tures (Perier, 1965), before being used in vivo as demyelinating
agent following injection in the white matter of the mouse spinal
cord (Hall, 1972). Focal demyelination and remyelination is also
observed following ethidium bromide injection. The first reports
using ethidium bromide as a demyelinating toxin involved intra-
cisternal injection in the rat (Yajima and Suzuki, 1979) or local
injection in the cat spinal cord (Blakemore, 1982). Another
widely used model consists in the introduction of cuprizone into the
diet of adult mice for several weeks. This treatment results in focal
demyelination of the superior cerebellar peduncle and the corpus
callosum. When allowed to recover on a normal diet, mice rapidly
remyelinate until a complete repair of all axons (Blakemore, 1973;
Ludwin, 1978). Despite their considerable advantages compared
with EAE models, toxin-mediated models are still quite demanding
and not ideally suited for large screening of compounds potentially
favoring remyelination.
More recently a novel screening for potential promyelina-
tion compounds was developed using laser ablation of GFP-
expressing oligodendrocytes in zebrafish larvae (Buckley et al.,
2010). However, as stated above, the large differences of myelin
constituents usage between teleost and higher vertebrate may be
misleading to translate from the zebrafish to human. In this re-
spect, Xenopus tadpole provides a signficant advantage over ze-
brafish. In addition, and in comparison with other in vivo animal
models of demyelination, the NTR suicide gene allows a simple
conditional and reversible demyelination. Introduction of the
demyelinating agent in the water avoids stereotactic intracerebral
or spinal cord injections. In comparison with cuprizone, which is
also introduced in the nutrient, MTZ-induced demyelination is
much faster (3 d vs 6 weeks) and the extent of demyelination can
be monitored from 50% to	100% simply by varying the dura-
tion of MTZ treatment, between 3 and 11 d, respectively (com-
pare Figs. 3 and 7). Another advantage of our Xenopus model is
the rapidity of remyelination, an important criterion for large-
scale screening of molecules. Finally, and of particular interest
also for screening, amphibian tadpoles can be produced in very
large numbers (thousands of transparent embryos, which de-
velop in water).
In conclusion, the pMBP-eGFP-NTR Xenopus described here
should prove useful, not only to identify either new therapeutics
targeted at promoting myelin repair or reprofiling currently
available drugs, but also to exploit the transparent feature of the
tadpoles to visualize and record the process and mechanisms of
myelination, demyelination and remyelination in vivo.
Figure 7. Retinoic acid improves spontaneous oligodendrocyte recovery. pMBP-eGFP-NTR
tadpoles at stage 50were treated for 11 dwithMTZ (10mM), then put either in freshwater or in
water containing 13-cis-retinoic acid (100nM) for 3 additional days. GFP cellswere counted in
vivo on the optic nerve. Note that in the control animal the number of GFP cells continued to
decrease even 3 d after cessation of MTZ treatment, in contrast to tadpoles exposed to retinoic
acid (n 6, p 0.03). *p 0.05 and ***p 0.001, significant differences.
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